Research conducted by the PDSA in 2017 found that 75% of dogs had received a primary vaccination course when young, which dropped to 72% in 2019. According to the BSAVA, it's the first time that vaccination rates have seen a sustained drop over a three year period since vaccinations were first introduced to the UK in the '60s.
The project, titled 'A mixed methods approach to quantifying and characterising vaccine uptake and vaccine hesitancy in UK companion animals' will combine quantitative analysis of existing data from electronic health records with qualitative approaches. It will include interviews and focus-group discussions with vets and owners to gain an in-depth understanding of patterns of uptake of vaccination in UK.
Experiences, perceptions and behaviours around uptake of vaccination and the rise of vaccine hesitancy in UK pet owners will also be investigated.
Dr Gina Pinchbeck, project leader at the University of Liverpool said: “Vaccination is a vital component of preventive healthcare and it is well acknowledged that sub-optimal vaccination uptake may be associated with re-emergence of vaccine-preventable diseases in populations.
“It is essential that we understand the reasons for vaccine hesitancy in the pet population so that we can use the best methods to promote vaccine acceptance and uptake and this will be the primary focus of the study.”
The study will include the development of a knowledge and dissemination strategy, in association with PetSavers and BSAVA. This will include a project website, publication of scientific research and other articles for both practicing veterinary surgeons and for pet-owners, press releases, conference presentations and public-engagement presentations.
BSAVA President Professor Ian Ramsey added: “This project will be of great value to the veterinary profession and continues the co-operation between BSAVA and the University of Liverpool to build on the successes of the original SAVSNET partnership.”
For information on how to apply for the PhD, contact Dr Gina Pinchbeck (ginap@liverpool.ac.uk).
Reference
The open day will cover topics including radiography, wounds and TPLO surgery aftercare, hosted by Dr. Michael Hamilton, consultant orthopaedic and spinal surgeon, Dr Karla Lee, head of soft tissue surgery and Letty Piggott-Delves, physiotherapy team lead.
There will also be an IMHA case discussion with internal medicine nurse Rute Silva, and an interactive quiz on anaesthesia for attendees to take part in, led by anaesthesia nurse practitioner Kimberley Brady.
Rachel Pickles, clinical services manager at Hamilton Specialist Referrals, said: “The open day is a brilliant opportunity for nurses from all over the veterinary profession to build on their existing knowledge base.
"It also presents an excellent learning opportunity for student nurses too, giving them access to educational sessions and workshops with members of our expert team.”
For more information and to RSVP, email info@hamiltonspecialists.vet or call 01494 578 566.
www.hamiltonspecialists.vet.
APPA is an oral, patented, fixed-dose combination of two synthetic secondary metabolites of plant origin, apocynin and paenol.
Under the terms of the agreement, AKL’s unnamed partner will fund a study in dogs with naturally occurring OA. The study will compare the efficacy and efficacy duration of APPA with the current standard of care for treating canine OA: non-steroidal anti-inflammatory drugs.
David Miles, AKLRD CEO, said: “Just like humans, millions of dogs suffer intolerable pain and disability because of OA and the current treatments just aren’t as effective or as well tolerated as they need to be. We already know from previous canine studies that APPA reduces pain and has an excellent tolerability profile but this exciting new partnership will allow us to go one stage further and assess sustainability of response.”
The randomised study will assess pain and duration of response as the primary endpoint. Secondary endpoint assessment will include adverse events, quality of life, pharmacokinetics analysis and biomarkers that may enable potential identification of factors predictive of response at treatment onset, or that correlate with response magnitude.
Two separate studies on dogs have already been carried out by researchers at the University of Vienna. The first, an 11-week cross-over study of 32 canines diagnosed with established, naturally occurring OA, showed that APPA provides significant symptom relief in clinical canine OA1.
A follow-up, five-week study of 60 dogs with OA compared APPA to the standard of care drug, meloxicam. It concluded that daily oral administration of APPA was effective as a stand-alone alternative to NSAIDs in dogs with naturally occurring OA. Significant benefits were also seen for APPA over meloxicam in orthopaedic examination as well as in lameness and function scores2.
The results will inform the pivotal clinical trial design and AKL says its working assumption is that a 26-week field study would complete the regulatory requirements for commercialisation.
If the study and future testing is successful, AKL estimates that APPA would be well placed to capture a significant share of the global canine OA market, which is estimated to be worth $3billion by 20283.
References
32% said they find dog care to be too restrictive
29% said it would be too difficult to go on holiday
24% said they don’t want to walk the dog every day and 25% that having a dog is too expensive.
41% of those who said they regret getting a dog bought it during lockdown.
BVA’s advice comes as the four nations of the UK launch contact tracing programmes to move from blanket lockdown restrictions to a more targeted approach, in line with strategies to ease lockdown restrictions.
Although slightly different across the UK, each programme will ask those who test positive for coronavirus to identify people they have been in recent contact with and those people will be contacted and asked to self-isolate for 14 days.
Relevant contact appears to be spending more than 15 minutes within two metres of another person or being in direct face-to-face contact (less than one metre) with them. At present, the schemes are voluntary, but may become mandatory at a later stage.
Northern Ireland: Test, trace, isolate, supportEngland: NHS Test and TraceScotland: Test and ProtectWales: Test Trace Protect
Employees in self-isolation are entitled to Statutory Sick Pay for every day they are in isolation, as long as they meet the eligibility conditions. Further roll out of testing may enable people to return to work sooner that 14 days if they receive a negative test.
BVA President Daniella Dos Santos said: "The next step in the Covid-19 response is shifting to a more targeted approach, but it’s clear that this could have a very significant impact on individual veterinary practices if a member of the team tests positive. The nature of veterinary work means we are in close contact with our colleagues in order to work safely with animals.
“Many veterinary teams will be understandably anxious about the impact on their ability to staff a full rota to maintain 24/7 care. And there are significant concerns about the impact on animal health and welfare if practices are unable to provide veterinary services.
"Our advice is to continue working in fixed pairs or small teams as much as possible to reduce your contact with different individuals and continue to practise good hygiene and biosecurity.
"We continue to ask neighbouring practices to work together to support those impacted by self-isolation and ensure full geographical cover for veterinary services.
"We recognise some veterinary professionals will be worried, but we urge everyone to comply with the contact tracing programmes."
Brian (pictured right), said: “I am absolutely delighted that Colourful CPD has joined Agilio and I see this as a win-win-win for Colourful CPD, Agilio and the veterinary profession.
"Colourful CPD’s courses complement Agilio’s vast array of existing statutory and mandatory courses which they already distribute within the UK as well as all around the world, thus enabling Colourful CPD to make the move up to the next level, both here and abroad.
I believe veterinary practices, as well as all the roles working within them, will benefit from being able to access a range of new courses and management services from Agilio.”
To mark its expansion into the veterinary sector, Agilio will be launching iTeam, its HR and rota software, together with iLearn, an online training and CPD accredited platform at the London Vet Show in November.
https://www.colourfulcpd.comhttps://agiliosoftware.com
It is the first time this Ofqual-regulated qualification has been offered to small animal first opinion practice nurses in the UK.
The new Level 5 qualification is designed for RVNs who have been qualified for at least six months and who have access to working in an emergency and critical care (ECC) environment.
CVS says it will help them to advance their knowledge and skills in ECC to a mastery level.
Students passing the course will gain post nominals and be placed on a register of Advanced Nurse Practitioners.
The course comprised six modules: the fundamentals of emergency and critical care, management of emergency and critical patient presentations, management of the emergency and critical patient, interventions for the emergency and critical patient, transfusion medicine and collaborative practice and wellbeing within the emergency and critical care setting.
The course will be taught online, with live tutor sessions and webinars, supported by an interactive virtual learning platform.
It will last 12-18 months, with enrolment through CVTC.
To apply, visit www.chestervtc.co.uk to complete an application form or email the Centre nursingschool@cvsvets.com .
Teleradiology company, VetCT, is calling for companies developing and deploying AI in the field of veterinary diagnostic imaging to impose the highest standards of self-regulation. In an AI position statement released on their website, the company highlights the opportunities and risks associated with the use of AI to interpret diagnostic images.
In the joint statement, company owners Victoria Johnson and Julien Labruyère (pictured right), said: “We strongly welcome the introduction of appropriately developed, tested and implemented AI tools into our profession, to provide solutions to improve resourcing and benefit animal welfare.
“There is a limited pool of veterinary radiologists and an ever-increasing need for expert interpretation of radiographs and more advanced diagnostic imaging modalities.
"This presents a huge opportunity for the development of AI and related technologies to better address demand, save time and potentially improve clinical knowledge and outcomes.
"However, it is important to note that, unlike human radiology, there is no official framework for the regulation, governance and quality control of AI tools in veterinary radiology.
"This means that there should be a very strong onus on companies and individuals to adhere to the highest standards of medical tool development when creating AI solutions.”
“If AI is released into veterinary practice without appropriate oversight or governance there is a significant risk of misleading results, misdiagnosis, and negative impacts on patient welfare.
"This, in turn, may undermine trust in AI and create a culture of hesitancy to adopt new technologies at a time when innovation is much needed to improve access to advanced care.”
The company is advocating for a series of self-regulatory measures to be applied by companies developing AI in order to safeguard both animal welfare and the liability of the veterinary surgeons using these tools in clinical practice.
The full position statement and a list of recommendations can be here: https://www.vet-ct.com/gb/our-services/ai-veterinary-radiology/
The operation of the equipment is being overseen by Dr Rodney Ayl, a specialist in both medical and radiation oncology. He said: "The need for protection of personnel during preparation of cytotoxic drugs presents the most significant obstacle to the safe provision of chemotherapy, as most practices are not equipped with an appropriate biosafety cabinet. This is especially true when there is a high case-load of chemotherapy patients."
Dr Ayl says the dangers of repeatedly handling and administering cancer drugs can be severe. He added: “The likelihood of drug exposure must be taken into account when considering the safety of personnel who handle cytotoxic drugs.
"The cumulative toxicity to personnel that arises from repeated contact with these drugs can cause health problems in the nursing staff that are beyond those expected in the patient.
"The main routes of personnel exposure to cytotoxic drugs are by aerosolisation or by absorption through skin.
"Both types of exposure can occur when preparing drugs for administration. The act of withdrawing cytotoxic drug from the vial into a syringe is generally the step that presents personnel with the greatest potential for exposure to a high concentration of drug.
"Ideally, personnel are optimally protected from drug exposure, and patients are protected from contamination of the product, by the use of a laminar flow biosafety cabinet (BCS) during drug preparation, regardless of whether a closed delivery system is used.
"The Envair CytoFAST BSC has been designed to guarantee the product, personnel and environmental protection.
"It belongs to the latest generation of laminar airflow systems and is built to the highest quality to guarantee the strictest safety standards - and the safety of our people is paramount at Paragon."
The talk, entitled “Rabbit Dentistry: It Takes Two”, will be co-presented by Craig Tessyman, an exotics veterinary nurse who works alongside Molly at Rutland House Referral Hospital. Their talk will cover the diagnosis and management of dental disease. It is aimed at any veterinary surgeon or nurse who wants to learn more about best practice in rabbit dentistry.
Molly, who holds both a Certificate and Diploma in Zoological Medicine, said: "Dental disease is common amongst pet rabbits, so small animal vets often need to diagnose and treat dental problems.
"It can be challenging to manage these cases. Our aim with this talk is to help vets improve their clinical approach, and also to provide useful tips for nurses – we want to explain how the practice team can work together with these cases, along our theme of ‘it takes two’."
Molly and Craig’s presentation will cover relevant background on the mechanisms of chewing in rabbits and provide practical advice on recognising and diagnosing dental disease. Physical examination and dental charting will be discussed, as well as dental radiography.
Molly said: "Radiography can be a really useful tool to assess dental disease in rabbits. Vets often aren’t as familiar with positioning and evaluating radiographs of rabbits as compared to cats and dogs, so we’ll give some useful tips on what to look out for."
Molly will share some advice on taking good dental radiographs, and then go into the details of interpretation, explaining how to use imaging to gain a more accurate diagnosis and enable more specific treatment. After this, she will discuss how best to plan and perform dental treatment. Incisor removal, cheek tooth extraction and pulpectomy are some of the topics she’ll cover.
The talk counts for 1 hour of CPD and will be held on 11th November at 12:20pm. Those who can’t make the live session can access a recording afterwards. More information and the sign-up link is available here: https://supremepetfoods.com/rabbit-dentistry-it-takes-two/.
The new suite offers chemotherapy and radiotherapy treatment facilities under one roof, including a linear accelerator (LINAC) which enables treatment of tumours previously considered untreatable.
Southfields has two full-time client-facing specialists in radiation oncology and two on-site, full-time double-boarded medical and radiation oncologists, along with dedicated radiotherapy technicians and therapeutic radiographers.
RCVS and European Specialist Sarah Mason, Southfield's lead in general oncology, said: “Southfields is already renowned as being the leader in cancer treatment for small animals in the UK and the opening of our dedicated oncology and radiotherapy suite takes patient care to an even higher level.”
www.southfields.co.uk
The company says the new addition leverages a combination of image recognition technology, algorithms, and cloud-based deep learning AI to enable accurate, in-clinic sediment analysis of fresh urine, delivering results within minutes.
The system evaluates red and white blood cells, squamous and other epithelial cells (e.g. urothelial and renal tubular epithelial cells), hyaline and non-hyaline casts, struvite and calcium oxalate dihydrate crystals, and cocci and rod bacteria.
Zoetis says its performance is comparable to that of a clinical pathologist.
Richard Goldstein, DVM, DACVIM, DECVIM-CA, Vice President and Chief Medical Officer, Global Diagnostics Medical Affairs at Zoetis said: “Urinalysis is an essential diagnostic test for veterinary surgeons, and often a good indicator of potential wider issues.
"Having the ability to get these results faster will improve the speed and level of care teams can provide their patients, facilitating efficient medical decision-making and helping to ensure smooth workflows.
The training will take place in locations across BSAVA’s regional network in the UK, and is open to large, small, and equine veterinary teams.
The sessions will cover the complexity of abuse and the impact of domestic abuse on children, how to recognise abuse/non-accidental injury in animals, how to document information and what to do when dealing with disclosure from a human victim of abuse.
They will also give guidance on setting up a practice protocol and identifying a practice links adviser who will assist those involved in the veterinary team to manage suspected cases of abuse.
Invited guests will include representatives from human and veterinary health, welfare bodies and policy makers.
Vicki Betton, Vice-Chair of The Links Group said: “We’re thrilled to be rolling out our programme of in-person training days with BSAVA.
"Abuse of any vulnerable member of the family, human or animal, is a difficult subject for many to even consider, but with reported cases of domestic abuse reaching an all-time high during the pandemic, its essential that teams are aware of the issue and have a practice protocol in place for if they feel something isn’t quite right with a case.
“We’re looking forward to exploring the most effective ways veterinary teams can recognise and act on suspected cases of non-accidental injury or disclosures of domestic or child abuse.”
The training days are free for BSAVA members and £50 (inc VAT) for non members.
So far, dates have been confirmed for Nottingham on 18th April and Exeter on the 29th June. Others are planned for the Metropolitan, Southern, Wales and North West regions.
To book your place, visit: https://www.bsava.com/education/cpd/regional-cpd
Alan, who is MD of the veterinary business consultancy, Vet Dynamics, will be looking at finances, the team, and scoping out a future strategy. The session will provide practical planning tools, strategic advice, and the opportunity to ask questions.
Bayer points to a number of trends which have emerged during lockdown which it says practices must respond to quickly in the post-lockdown recovery.
The company says retailers have reported that internet traffic increased threefold at the start of lockdown and it remains at double the pre-lockdown levels. Direct retail sales of flea and tick products have also increased.
This suggests that owners are becoming more comfortable with buying preventative healthcare products online.
Bayer says there is a business opportunity here for practices. The subscription box market is expected to hit £1 billion by 20222, and one way practices can capitalise on this trend is by offering home-delivered flea, wormer and tick treatments.
Another business opportunity could lie in research by Banfield Pet Hospital among 1,000 US pet owners in which 20% vowed to take their pets ‘more often’ to the vet post-lockdown for preventative care checkups3.
Caroline Braidwood, Regional Business Manager of Bayer Animal Health said: "We know that many veterinary customers have potentially gone elsewhere during the pandemic and vets will need to work hard to win them back. Our webinar will provide tangible insights to ensure that practices can flourish. Whether you’ve worked with Bayer or not, our team of Veterinary Business Managers are here to help. We’re all in this together, and with some planning, we can ensure the veterinary industry continues to grow.”
To book your webinar place, visit: https://event.webinarjam.com/register/46/rk71qav5
This year’s theme is 'Feline Fine: how to create harmony between physical health and mental wellbeing in your treatment and management of feline cases'.
The scientific programme will include lectures, interactive sessions and in-depth masterclasses from feline experts including Professor Danièlle Gunn-Moore (feline medicine specialist), Dr Sarah Heath (specialist in veterinary behaviour), Dr Matt Gurney (specialist in veterinary anaesthesia) and Professor Clare Rusbridge (specialist in veterinary neurology).
This is the third year that ISFM has hosted an annual congress event online, something the charity says has been a huge success, attracting over 3,000 veterinary professionals from 96 countries in 2021.
Dr Nathalie Dowgray, Head of ISFM said: "Whilst it was fabulous to be back in person in Rhodes this year, we cannot lose sight of the opportunity providing a virtual option gives the veterinary community."
The 2022 ISFM Virtual Congress is open to all veterinary professionals, including nurses, technicians and behaviourists who are interested in the relationship between feline emotions and behaviour, and other disciplines such as neurology, pain management, and internal medicine.
The live launch will feature a short lecture followed by a live Q&A session with iCatCare’s Vicky Halls (Cat Friendly Homing Manager), Linda Ryan (Registered Veterinary Nurse and Behaviourist) and Professor Danièlle Gunn-Moore.
ISFM Veterinary members will automatically receive a ticket to the Virtual Congress as part of their annual membership benefits.
https://icatcare.org/isfm2022congress-virtual/
As part of the University of Bristol, Langford is the only referral hospital in the South West which has an educational facility.
The new academy will also be developing its Veterinary Nurse Graduate Program and give access to its Vet Nurse Congress.
Juliet Morrison, Nurse Graduate Lead said: “At LV we passionately believe in nursing progression.
"Through our SAH Graduate Nursing Programme, we continue to support the next generation of nurses to become confident, resilient professionals.”
For more information, email: brm@langfordvets.co.uk
The Vet Nurse Merit Award courses are designed for RVNs in primary care practice.
The VNMA in Dentistry offers 30 hours of CPD and will help delegates feel confident in:
The programme consists of 10 recorded webinar sessions and an online resource which includes a discussion forum for delegates to connect.
A practical attendance course will take place at Woodrow House, Gloucester, which will give delegates the chance to meet colleagues who have been studying at the same time and get hands on experience in various practical sessions.
Fees for the VNMA are £570.00 for BSAVA members and £840.00 for non-members.
https://bsavaportal.bsava.com/s/community-event?id=a1mTw000000DrxlIAC
According to its latest Voice of the Veterinary Profession survey, 93% of vets are either ‘very’ or ‘quite’ concerned about the boom in unregulated canine fertility clinics.
Amongst vets who work in companion animal practice, 30% said they were aware of unregulated canine fertility clinics operating in their local area.
However, despite high levels of concern, 78% of vets said they didn't know how to report a clinic.
Even amongst those who do know how to report a clinic, only 8% had, which is about 2% of all vets.
BVA Senior Vice President Justine Shotton said: “Our survey reflects the magnitude of vets’ concern around canine fertility clinics popping up across the country with no veterinary oversight and should serve as a wake-up call for urgent regulatory action.
“While non-surgical procedures can play an important role in breeding programmes, we are clear that they must always be carried out under the advice and care of a vet and in the interests of dog health and welfare.
“We know that many fertility clinics often focus on the most in-demand breeds such as French bulldogs, which can struggle to mate and whelp naturally.
"BVA is very concerned about artificial insemination being used in such cases, as well as in cases where dogs with inherited diseases and conformation-related issues are used for breeding.
"We are also aware of worrying reports that some fertility clinics are advertising prohibited or dangerous procedures such as surgical artificial insemination.”
To report a fertility clinic:
Justine added: “I’d encourage vets to develop a practice protocol for reporting concerns of this nature and to make a note of the country-specific reporting mechanisms relevant to them.
"The more information the authorities have, the easier it is for them to take enforcement action.
"Working together we need to send a strong message that these animal welfare breaches are unacceptable.
“As veterinary professionals, we also need to work with, and support, our clients who are breeding responsibly and re-double our efforts to reach prospective puppy owners to help them make the right decisions when they choose a new pet.”
This brings the total reported the UK so far this year to eight, following 28 last year and 287 in total.
For a map of all confirmed cases and information for veterinary professionals and pet owners about CRGV, visit: www.alabama-rot.co.uk.
‘RVN Starting out’ takes around 10 hours to complete and is free to access at: https://academy.rcvs.org.uk/
VN Futures Project Manager, Jill Macdonald, said: “Our RVN Starting Out course has been created to support adapting to professional responsibility, optimising workplace learning opportunities and working effectively as part of a team.
"The course also assists newly-registered nurses with building confidence and considering their career development.
"We have included learning on key areas such as reflective practice, workplace culture, quality improvement, clinical decision-making and assertive communication to reflect the responsibilities that veterinary nurses now undertake."
“The course is delivered over six modules which can be completed individually and accessed at any time to fit around busy work schedules.”
The range includes a spray, collars and diffusers.
Unlike many other pheromone diffusers which need to be plugged into a wall socket, Virbac's uses a patent-pending slow release technology which doesn't need power.
Virbac says the new range has been scientifically proven with published studies which demonstrate not only their effectiveness in managing stress-related behaviours in dogs and cats, but also an equivalent and superior efficacy to the current market leading pheromone products 1,2,3
Andrew Connolly, Virbac's Marketing Director for the UK and Ireland said: "Veterinary professionals have a crucial role to play in supporting their clients with the behavioural management of their pets, both when visiting the practice and at home, and the benefits of pheromones in helping to manage dog and cat behaviour are already very well recognised."
"With Zenidog and Zenifel we hope to make pheromone therapy easier, more cost-effective and better for the environment."
Zenidog and Zenifel are available to order from NVS, Covetrus and VSSCo now.
The authors say that study seeks to redress the lack of evidence-based information that has so far been published on the epidemiology and clinical management of non-neoplastic anal sac disorders (ASD).
The study, which was carried out within the RVC’s VetCompass programme, focused especially on identifying breeds with increased or reduced risk of anal sac disorders.
The breeds at greatest risk of an anal sac disorder compared with crossbreeds included Cavalier King Charles spaniel, King Charles spaniel and Cockapoo.
Conversely, breeds at reduced risk included larger breed dogs including Boxer, German Shepherd Dog and Lurcher. Flat-faced (brachycephalic) breeds such as Shih Tzu had 2.6 times the risk for anal sac disorders compared to long-skulled breeds such as Border Collies. Spaniel-types, Dachshund-types and Poodle also showed increased risk for anal sac disease.
The study identified 2,372 anal sac disorder cases from a population of 104,212 dogs attending VetCompass participating practices during 2013.
Other findings included:
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology, at the RVC, and author of the paper, said: “During two decades in first opinion practice, anal sac problems in dogs were a routine daily presentation for me. However, when I searched the literature to find evidence on the best way to treat these dogs or even on which breeds were at most risk, there was almost no information available. It seemed back then that only problems that were severe enough to be referred to universities in large numbers were researched.
"As a result, vets in first opinion practice generally had to work out for themselves what seemed to be the best treatment in these cases. It is refreshing now to see research on common problems in dogs under first opinion veterinary care being reported. Owners and vets needs this evidence vitally.”
Anette Loeffler, Associate Professor of Veterinary Dermatology at the RVC and co-author of the paper, said: "This study shines a spotlight on critically important area of veterinary practice: antibiotic usage. Twenty percent of dogs presenting with an anal sac disorder received antibiotics even though diagnostic criteria for anal sac infection or proof of efficacy of antibiotic treatment are lacking.
"At a time when antimicrobial resistance presents one of the biggest threats to human and animal health, this highlights an urgent need for further study of these disorders in order to improve dog welfare but also to help vets in making responsible antibiotic treatment decisions in the interest of public health.”
The Good Veterinary Workplaces Voluntary Code sets out various criteria for what makes a good workplace, based on a new evidence-based BVA policy position.
The code is accompanied by a workbook which veterinary teams can work through together and consider how they might meet a range of criteria. They can also download, sign and display a Voluntary Code poster signalling their commitment to working towards being a good veterinary workplace.
Teams will be asked to assess what they already do well in areas including health and wellbeing, diversity and equality, workload and flexibility, and providing opportunities for personal and career development, as well as identifying areas for improvement and any HR and management processes that need to be put in place to achieve a positive workplace culture.
At the same time, the BVA has also launched its Good Veterinary Workplaces policy position, a paper which offers 64 recommendations for employers and staff on how to offer a fair and rewarding work environment where everyone feels valued.
The BVA says it decided to develop the Good Veterinary Workplaces policy off the back of an extensive body of work looking at workforce issues in the profession, including recruitment and retention challenges, a lack of diversity across the workforce, and general high levels of stress and burn-out in veterinary teams.
The joint BVA/RCVS-led Vet Futures project identified the need to explore the work-related challenges facing vets and take action to create a sustainable and thriving workforce that can maximise its potential.
Gudrun Ravetz, Chair of the Good Workplace Working Group, said: “I’m absolutely delighted to see the launch of our valuable and comprehensive policy, which sets out a vision of the good veterinary workplaces that we should all be striving to create across the profession. This vision has been shaped by valuable contributions from across the veterinary community, and it’s also been really useful to draw on good practice in the wider world of work.
“Each and every one of us deserves to work in a setting where we feel valued, supported and fairly rewarded for the contribution we make, but sadly this isn’t the reality for all veterinary professionals. By setting out the steps that all veterinary workplaces can take to offer a more welcoming and inclusive environment, with measures in place to help them address issues and continue to improve, we hope to see more workplaces where staff can thrive and enjoy a fulfilling career.”
Daniella Dos Santos, BVA Senior Vice President, said: “It’s time for us all to take action to create a culture shift in veterinary workplaces. That means taking positive steps so that diversity and inclusion is championed at all levels, all team members have access to personal and professional development opportunities, and there is recognition that prioritising staff wellbeing is good for businesses.
“In creating the Voluntary Code and workbook, we’ve purposefully made this something that isn’t driven from the top down but is instead something that everyone in the team can feel empowered to feed into and sign up to. This is a golden opportunity for our profession to take ownership of our workplaces, improve conditions, and make sure that we have positive working environments in which we can all take pride.”
Remend Corneal Gel is used to aid the healing process of superficial corneal ulcers in dogs, cats and horses while Remend Dry Eye Lubricant Drops is designed to give long-lasting moisture and lubrication for dry eyes in dogs.
https://www.tvm-uk.com
Launched by the VMG in 2021, the VMG Veterinary Leadership and Management course has three levels, the Award, the Certificate and the Diploma.
There are 151 Award holders, 39 Certificate holders and now one holder of the Diploma.
144 veterinary professionals are currently studying for the CVLM, which is accredited by the Institute of Leadership and Management (ILM).
In addition to the core modules, participants also select an additional topic tailored to their current or future needs, such as practice finance, HR, mental health and leading change.
Gemma said: “I wanted to study for the full qualification because I’m very interested in the whole subject of practice management and I really love learning.
"I experienced a few lightbulb moments, especially early on in the course when I was trying to work out what kind of leader I was.
"This section of the course opened my eyes to different leadership styles and the type of leader I wanted to become.
"I put this into practice over time, so when I came to study the team management section towards the end of my course, I could see my development over the past two years.”
She added: “Overall, I found the course very enjoyable. There is time to really dig into each topic and many different modules to choose from. The support on offer from the tutors is also excellent.”
The deadline for registration for the Winter term is 31st October.
www.vetmg.com/cvlm